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1. Introduction 
Aortic valve is located in the outflow tract of left ventricle (LV), the systemic ventricle, and it 
should provide LV with an open tract during systolic period in order to have a perfect tissue 
perfusion with the least energy consumed by LV, and a closed tract during diastole to 
prevent blood regurgitation from systemic circulation to LV in diastole to avoid acute and 
late consequences of LV volume overloading.  
Aortic valve diseases are mostly asymptomatic for a long period of time. This may 
culminate in irreversible LV damage before diagnosis.  
Nowadays aortic valve replacement (AVR) for aortic stenosis is the most frequent cause of 
cardiac valvular surgery, because most of the mitral valve procedures are performed 
precutaneously. 
1.1 Aortic root anatomy 
Aorta is mainly composed of two parts: abdominal and thoracic, before it bifurcates to two 
common iliac arteries. The thoracic aorta is divided to three parts. The first one is ascending 
aorta which extends from aortic root to the arch of aorta and has no branches. The arch is the 
second part which has three main branches: Brachiocephalic artery, Left common carotid 
artery and left subclavian artery. After the last branch the descending aorta begins which 
extends inferiorly and passes through diaphragm where it turns to the abdominal aorta.  
 Left ventricle connects to ascending aorta via aortic root which provides the supporting 
structures for the leaflets of the aortic valve and the heart (Anderson 2000), and forms the 
bridge between the left ventricle and the ascending aorta. There is still no consensus as how 
best to describe the components of the root (Antunes 2005). The root itself, surrounding and 
supporting the leaflets, has length in that it extends from the basal attachments of the 
leaflets within the left ventricle to the ascending aorta (Anderson 2007). The very proximal 
part of aorta after leaflets is somehow dilated and is named sinus of valsalva. Its function is 
to support the leaflets and also right and left coronary arteries arise from this part of aorta. 
The tubular portion of ascending aorta is just after sinus of valsalva and the junction of this 
two parts is named sinotubular junction. (Figure 1, 2). The aortic valve itself is composed of 
three leaflets which attach to the aortic root like a crown (Figure 3). This crown like structure 
is essential for the function of the valve and in some congenital disorders of the valve such 
as bicuspid aortic valve restoration of this structure will result in better valvular function 
(Pretre et al., 2006). The aortic ring is the part that these leaflets attach to. These leaflets  
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attachment vary in the way that some of them attach to the muscular part of LV and some of 
them to the fibrinous part of the ring (Anderson 2000)  
In conclusion the left ventricular blood goes to left ventricular outflow tract which ends in 
aortic root which is composed of aortic valve, aortic ring, sinus of valsalva and the 
sinotubular junction. 
 
Anatomic ventriculo-aortic junction
Sinutubular junction
Virtual basal ring
Semilunar attachments
 
(Reproduced from Robert H. Anderson. The surgical anatomy of the aortic root.  
doi:10.1510/ mmcts. 2006.002527 with permission.) 
Fig. 1. The anatomy of Aortic Root 
2. Aortic stenosis 
2.1 Definition 
Aortic stenosis (AS) means obstruction in left ventricular outflow tract (LVOT). It can be 
easily divided to three categories: subvalvular AS, valvular AS and supra valvular AS. 
Valvular AS is the most common cause of LVOT obstruction. Sub valvular AS comprises 
hypertrophic obstructive cardiomyopathy and sub aortic web. These two entities are almost 
always congenital but may show themselves later in the life. Supra valvular aortic stenosis is 
mainly part of complex congenital anomalies such as William syndrome that is associated 
with hypercalcemia. Valvular aortic stenosis is the mainstay of this article. It’s a slowly 
progressive disease which progresses over time and causes a gradually aggravating LVOT 
obstruction. In an adult the average aortic valve area is about 4cm2 and the normal aortic 
valve area should be at least 2cm2. Areas less than that are defines as aortic stenosis. There 
are some other definition criteria by echocardiography or cardiac catheterization. Aortic 
flow peak gradient more than 20 mmHg in echocardiography (Baumgartner 2009) (Bonow 
2006 ACC AHA guidelines) or in left side catheterization is also defined as AS. But the best 
definition is always the surface area of the valve because these gradients can be influenced 
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(Reproduced from Robert H. Anderson. The surgical anatomy of the aortic root. 
doi:10.1510/ mmcts.2006.002527 with permission.) 
Fig. 2. The anatomy of Aortic Root 
 
Anatomic ventriculo-aortic junction
Vitrual basal ring
Sinotubular junction Crown-like
semilunar attachments
 
(Reproduced from Robert H. Anderson. The surgical anatomy of the aortic root. 
doi:10.1510/ mmcts.2006.002527 with permission.) 
Fig. 3. The anatomy of Aortic Root 
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by the cardiac output of the patient. In a normal man with anemia the cardiac output is 
increased to compensate for the decreased oxygen carrying capacity of the blood. This can 
cause increase in flow velocity across the valve and the overestimation of the gradient and a 
false diagnosis of an AS or overestimation of the AS severity. On the other hand in a patient 
with severe AS and advanced LV dysfunction the left ventricle do not have enough power 
to pump the blood across the valve and the trans-valvular jet velocity and gradient will be 
falsely low. This can have therapeutic importance because if these kind of patients are not 
diagnosed as AS their only option is medical therapy with limited outcome but with the 
proper diagnosis and alleviation of LVOT obstruction LV function will restore although 
partially (Bonow 2006 ACC AHA guidelines).  
2.2 Etiology 
AS is the most common valvular heart disease in human (Kurtz 2010). Most cases of adult 
aortic stenosis are caused by calcification of normal tricuspid or bicuspid aortic valve 
(Bonow 2006 ACC AHA guidelines). These are most commonly seen in elderly and those 
older than 65. The third most common cause of AS is rheumatic heart disease which is 
highly associated whit mitral valve disease as well. There are couple of other etiologies for 
AS which are all rare, they include homozygous familial hypercholesterolemia, congenital 
heart disease (other than bicuspid aortic valve such as unicuspid aortic valve), radiation 
induced aortic stenosis. 
2.2.1 Calcific degenerative aortic stenosis (CDAS) 
This is the most common cause of aortic stenosis. This is also called senile degenerative 
aortic sclerosis and stenosis, but the pathophysiology of this disease is not an irreversible 
simple age related degenerative disorder. On the other hand Calcific AS is an active disease 
process characterized by lipid accumulation, inflammation, and calcification, with many 
similarities to atherosclerosis (Bonow 2006 ACC AHA guidelines)(Kurtz 2010). CDAS is 
started by accumulation of lipid particles and oxidized low density lipoprotein (LDL) in 
aortic leaflets just like precursors of atherosclerosis plaque. This particles and their oxidative 
products cause activation of local lymphocytes and macrophages and production of 
angiotensin II, which all ultimately convert leaflet fibroblasts to osteoblasts which are the 
cells that produce bony and calcific structure. These cells are responsible for calcium 
deposition in CDAS. These changes start from the base of the leaflet and extend to their tip 
but no leaflet and commissural fusion happens like the one seen in rheumatic heart disease. 
These changes resulted in emergence of therapeutic medical ideas for treatment of AS. The 
most important of them are STATINs which are lipid lowering agents. Unfortunately 
clinical trials have not showed any benefit in reversing CDAS by STATINs. Chan KL et al., 
(2010) studied this concept and their result was that Cholesterol lowering with rosuvastatin 
40 mg did not reduce the progression of AS in patients with mild to moderate AS; thus, 
statins should not be used for the sole purpose of reducing the progression of AS. The main 
reason may be the advanced degenerated calcific nature of the disease. These changes are 
very similar to those that occurs in vascular atherosclerosis and actually they have similar 
risk factors, both are more prevalent in patients whit diabetes mellitus, hypertension, 
hyperlipidemia and renal failure. CDAS is accelerated in patients with intrinsic aortic valve 
disease such as bicuspid aortic valve. 
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2.2.2 Bicuspid aortic valve 
This is the most common congenital cause of AS and the most common cause of AS in 
neonates and the most common cause of CDAS in those younger than 60. Bicuspid aortic 
valve can be associated with sever aortic regurgitation but most commonly it is associated 
with AS before 60. Also it is associated with diseased aortic wall which can culminate in 
aortic aneurysm as well as aortic dissection( Roberts 1970). Most of the time replacement of 
aortic root is indicated during operation of the valve in bicuspid valve patients. Some have 
reported the repair of the valve and restoration of normal crown structure of the aorta as the 
surgical therapeutic modality for bicuspid aortic valve(Pretre et al., 2006) 
2.2.3 Rheumatic AS 
It is the third common cause of AS. Its prevalence is decreasing because of increasing proper 
management of streptococcal pharyngitis. It’s almost always associated with some amount 
of aortic regurgitation and mitral stenosis. In fact rheumatic fever only involves aortic valve 
in one third of the patients. It most commonly involves tip of aortic leaflets with thickening, 
commissural fusion and finally calcification which causes doming of the valve in 
echocardiography. It is important to remember to evaluate the mitral valve in every patients 
with rheumatic AS(Bonow 2006 ACC AHA guidelines)( Kurtz 2010). 
2.3 Pathophysiology of LV changes induces by AS 
AS is the most common cause of LV outflow tract (LVOT) obstruction.It progresses slowly 
over the time, so the LV can compensate for the pathologic changes that it can cause. AS 
causes increases resistant in LVOT and the after load of the LV (which is the force that the 
LV contracts against). This results in increased wall stress of LV. Wall stress is equal to 
pressure of LV multiplied by radius of LV divided by wall thickness of LV: 
Wall stress=Pressure× radius / ( 2×wall thickness) 
Increased wall stress can cause ischemia and ultimately myocardial damage. LV increases its 
own thickness by hypertrophy to compensate the increase in wall stress. This can 
compensate for the increase in after load and LV ejection fraction(LVEF) remains in normal 
range. But if the amount of hypertrophy is less than enough the LVEF will decrease , this is 
called after load mismatch and can be corrected by alleviating the obstruction in LVOT. On 
the other hand in some patients the decrease LVEF is due to intrinsic myocardial damage. In 
these patients even aortic valve replacement cannot increase the LV function. Increased LV 
thickness and hypertrophy is not all physiologic and has some negative effects on the 
myocardium. First of all the hypertrophied myocardium has less coronary blood flow 
reserve(Marcus 1982) that exposes it to ischemia specially during exercise. Then is the fact 
that the hypertrophied myocardium is more sensitive to a constant level of ischemia 
compared to normal myocardium. The final problem is over hypertrophy which is almost 
exclusively seen in old women. This can cause even high LVEF but conversely is associated 
with high operative mortality(Bonow 2006 ACC AHA guidelines). In the majority of AS 
patients the final step is the time that LV hypertrophy cannot compensate for increased after 
load and LV Dysfunction ensues. This is the step that the patient finally becomes 
symptomatic. That’s why a patient with AS has a good prognosis till he or she is 
asymptomatic, and stays symptom free for a long time, but as soon as the symptoms emerge 
the prognosis of the disease worsens and progresses rapidly by LV failure. 
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2.4 Sign and symptoms 
Unfortunately AS is asymptomatic for a long period of time. AS symptoms is mainly due to 
3 physiologic phenomena: cardiac ischemia, elevated LV filling pressure, and decreased 
cardiac output (Kurtz 2010). The first symptom in most cases is dyspnea in exertion. The 
dyspnea progresses over time and the more the disease progresses the less will become the 
level of the activity that the patient can take without dyspnea. Finally the patient will have 
dyspnea at rest. All three mentioned phenomena’s are responsible for dyspnea. The second 
common sign is chest pain which is again seen in specially on activity. The cause of the chest 
pain is multi-factorial. Half of them have coronary artery disease (CAD) which can cause the 
chest pain. In those without CAD the chest pain caused by increased demand because of LV 
hypertrophy and decreased aortic pressure because of the AS itself. Also as mentioned 
decreased coronary flow reserve can cause real ischemia in AS. Syncope specially during 
activity is the third common symptom and is caused because of low cardiac output , and 
decreased cerebral perfusion. Other causes of syncope are inappropriate vasodilatation 
because of abnormal myocardial receptor activation (reflex mediated syncope) and rarely 
arrhythmias. Sudden cardiac death usually happens in 1% of patients and occurs mostly in 
those with other symptoms and not as the first presentation. Peripheral embolization and 
heart failure are rarer symptoms of AS and are mostly seen in final stages of the disease. 
There is a very special symptom in AS patients that happens because of vascular dysplasia. 
AS patients can have angiodysplasia in their right colon. the exact reason of this vascular 
abnormality is not known but it can be due to increased shearing stress and platelet 
activation. This problem is associated with gastrointestinal bleeding and is relieved after AS 
is corrected. Although the patient may have no symptom, in physical examination we can 
find couple of symptoms that can relive the problem. The peripheral pulses and cardiac 
auscultation are the main targets in physical examination. The best pulse to evaluate is 
carotid pulse. It becomes narrow and the time to the peak pressure increases. this is called 
pulsus parvus et tardus. In cardiac auscultation a mid-systolic ejection murmur which is 
crescendo decrescendo can be heard in right second intercostals space which radiates to the 
right side of the neck. Also aortic ejection click can be heard in those patients whose valve is 
not heavily calcified. Heavy calcification of the valve can decrease the doming of the valve 
which is the main cause of the ejection click. The severity of the murmur although helpful in 
assessing the severity of AS, can be influenced by the level of cardiac output and be 
misleading. 
2.5 Evaluation of patients with AS 
The evaluation begins with meticulous history taking and physical examination. The quality 
of pulses, second heart sound, systolic murmur and peripheral signs of heart failure are 
used for diagnosis and determining the severity and prognosis of the disease. Narrow pulse 
pressure and systolic murmur of grade III or more and signs of heart failure are usually 
associated with severe AS, although the severity of the murmur can be influenced by the 
level of the cardiac output (it increases with increased cardiac output like anemia). 
Symptoms of the patient are very important because even in the presence of normal LV 
function emergence of symptoms are strong indication for aortic valve replacement (Bonow 
2006 ACC AHA guidelines)(Kurtz 2010). It is important to obtain specific history for 
dyspnea and exercise intolerance as the patient may ignore them because of the chronic 
nature of the disease. Electrocardiography (ECG) is the next tool to evaluate the patient, 
which shows LV hypertrophy, abnormal ST-T changes, arrhythmias, atrio-ventricular and 
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inter-ventricular conduction abnormalities. Inter-ventricular conduction delay specially left 
bundle branch block is mostly seen in advanced myocardial dysfunction. ECG is primarily 
important in diagnosing the associated cardiac problems such as ischemic heart disease, and 
all of the findings that can be seen in AS are neither specific nor sensitive. Echocardiography 
is the most commonly used and the most practical mean of diagnosing and evaluation the 
severity of AS and associated conditions. There are multiple echocardiographic modalities 
such as 2D imaging, Doppler mode and color Doppler mode for this purpose (Table 1). The 
aortic valve area can be measured by 2-D echocardiography via parasternal short axis view 
of the aorta. Also Doppler echocardiography can measure the valve area by continuity 
equation. This is based on the rule that the amount of blood that passes the LVOT is equal 
the blood that crosses the aortic valve. 
Aortic valve area= LVOT VTI× LVOT AREA/  Aortic valve VTI 
Where VTI is velocity time integral and can be calculated easily by Doppler echocardiography. 
The easiest and most commonly used method is assessing trans valvular flow velocity and 
gradient. AS then can be categorized to mild, moderate and severe. (Table 1) Other imaging 
tools such as CT scan and MRI are also useful. They can specially evaluate the ascending 
aorta that can be dilated and aneurismal in AS. Cardiac catheterization is almost always 
used when the previously mentioned modalities fail to accomplish the diagnosis or when 
there are conflicts between them. 
 
 
Table 1. Assessment of AS severity by echocardiography (Source: American Heart 
Association, Inc.) 
2.6 Medical management of patients with AS 
AS does not have a medical treatment, but the medical follow up is very important before 
AVR to determine the perfect time of operation according to guideline and charts, and post 
AVR for proper anticoagulation and complication management. Periodic echocardiographic 
and clinical evaluation of the patients with AS is the main nonsurgical management of AS 
patients. This intervals are determined by the severity of AS and patients symptoms. Those 
with mild AS should be evaluated every 3-5 years, patients with moderate AS every 1-2 
years and severe AS should be evaluated yearly. Also pregnant women and those who 
become symptomatic should have prompt evaluation (Bonow 2006 ACC AHA guidelines) 
(Kurtz 2010). Other major medical therapy targets associated risk factors such as hypertension, 
hyperlipidemia and diabetes mellitus. Endocarditis prophylaxis is no longer needed for AS 
patients because the risk of infection is low. Many investigators have tried to find a way to 
delay or even reverse the progression of AS. There are couple of reports that some drugs 
such as STATINs may have some effect in slowing the progression of AS, but most studies 
have failed to show any effect. Rosenhek et al., (2004) compared the effect of angiotensin 
converting enzyme inhibitors (ACEIs) with statins in reducing AS progression. According to 
their study ACEIs do not appear to slow AS progression. However, statins significantly 
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reduce the hemodynamic progression of both mild-to-moderate and severe AS, an effect that 
may not be related to cholesterol lowering. On the other hand Chan et al., (2010) reported 
that Cholesterol lowering with rosuvastatin 40 mg did not reduce the progression of AS in 
patients with mild to moderate AS. 
2.7 Endovascular management of patients with AS 
This method is mostly used during childhood according to specific guidelines and with 
specific methods. In adults this procedure has little value because of high risk of 
complication, procedure failure and high rates of recurrence on the contrary in childhood 
the valve is more pliable and the success rate of the procedure is high, so precutaneous 
aortic valvoplasty is the standard procedure for treatment of AS in childhood. Nevertheless 
precutaneous balloon valvoplasty can be performed in highly selected adult patients such as 
those with very high surgical risk and also as a bridge to AVR in those with decompensated 
condition. Although it cannot replace for standard AVR procedure (springing 1995)(Webb 
2006). The other option is precutaneous valve replacement. Three different methods are 
available but all of them are associated with high mortality and morbidity and are not 
routinely performed. 
 
• Class I: Conditions for which there is evidence for 
and/ or general agreement that the procedure or 
treatment is beneficial, useful, and effective. 
• Class II: Conditions for which there is conflicting 
evidence and/ or a divergence of opinion about the 
usefulness/ efficacy of a procedure or treatment. 
• Class IIa: Weight of evidence/ opinion is in favour 
of usefulness/ efficacy. 
• Class IIb: Usefulness/ efficacy is less well 
established by evidence/ opinion. 
• Class III: Conditions for which there is evidence and/ or 
general agreement that the procedure/ treatment is not 
useful/ effective and in some cases may be harmful. 
Table 2. Definition of multiple classes (Source: American Heart Association, Inc.) 
2.8 Surgical management of AS 
Aortic valve repair for AS is almost never done because of high rate of failure therefore AVR 
is the standard management of AS. Although Pretre et al., (2006) reported repair of bicuspid 
aortic valve and restoration of normal anatomical crown like structure, AVR is still the 
procedure of choice for AS patients. The timing and indication of surgery is determined 
through specific guidelines (Figure 4 and Table 2). the most important issues in this manner 
are patients symptoms and LVEF. Symptomatic patients or those with LVEF less than 50% 
should undergo AVR. There are multiple kinds of prosthetic valve. Each kind has its own 
properties. Selection of the prosthetic valve is also done via the guidelines. Aortic root size is 
the other important issue that should be considered before operation. Aortic root size 
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should be exactly determined with CT scan or MR. Aortic root more than 4.5 cm specially in 
those with bicuspid aortic valve or marfan syndrome is an indication for aortic root 
replacement. This operation is called Bental operation and involves a metallic prosthesis 
sewed in a Dacron artificial ascending aorta that is replaced for aortic root (Hiratzka 2010). 
 
Severe Aortic Stenosis
   Undergoing CABG
or other heart surgery?
  Vmax greater than 4 m/s
     AVA less than 1.9 cm
Mean gradient > 40 mm Hg
Re-evaluation
No
Normal
LV ejection fraction
Normal
Equivocal
Exercise test
Less than 0.50
Yes
Yes
Symptoms
↓BP
Aortic Valve Replacement
Preoperative coronary angiography
 Severe valve calcification,
rapid progression, and/or
expected delays in surgery
No
Clinical follow-up, patient education,
risk factor modification, annual echo
Symptoms?
Class I      Class I     Class IIb     Class I     Class IIb
 
Fig. 4. Timing of operation in AS patients (Source: American Heart Association, Inc.) 
2.9 Natural course of AS 
Frank S et al (1973) studied the natural history of the patients with severe AS who did not 
undergo AVR. He showed that during a 10 year follow up 90% of the patients will die 
without surgical intervention. He also found that those with combination of symptoms such 
as dyspnea. Angina and syncope has the worst prognosis. Aortic stenosis has good 
prognosis when it’s asymptomatic and its mortality rate is almost the same as those without 
AS. But as soon as it gets symptomatic the survival is only about 2-3 years without 
treatment. The mean survival is 5, 3, 2 years for angina, syncope and heart failure 
respectively (Kurtz 2010). With operation in perfect time the survival will remain good. 
After operation patients should be evaluated by history and physical examination yearly. 
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3. Aortic insufficiency 
3.1 Definition 
Inability of aortic valve to withhold regurgitation of blood from aorta to LV in diastole is 
defined as aortic insufficiency (AI) or aortic regurgitation. It is not as prevalent as AS but it 
can be seen in at least 75% of patients with CDAS. The main difference of AS and AI is that 
AS imposes a systolic pressure over load to the LV, in contrast to AI that mainly increases 
the diastolic LV load. Thus LV dilatation during asymptomatic period is more prevalent in 
AI. 
3.2 Etiology 
It can be divided into problems of the valve itself and those that are due to aortic root 
dilatation(Bonow 2006 ACC AHA guidelines). Diseases that involve the aortic valve itself 
cause AI by disturbing the normal motion or normal coaptation of the leaflets. These 
include, congenital abnormalities of the aortic valve (most notably bicuspid valves), calcific 
degeneration, rheumatic disease, infective endocarditis, systemic hypertension, myxomatous 
degeneration. Anorectic drugs radiation and trauma are rare valvular causes of AI. 
Nowadays aortic root diseases are responsible for at least 50% of cases of aortic insufficiency 
(AI). It can be caused by systemic disorders such as hypertension or marfan syndrome or 
can be idiopathic. One interesting cause of AI is consumption of anorectic medications 
which can cause AI by damaging the valve itself. Most causes of AI cause a chronic disease 
that can be asymptomatic for even decades but some etiologies can cause acute sever AI that 
can be even fatal if left untreated. They include infective endocarditis, trauma and aortic 
dissection. Moaref et al. (2009) reported a case of acute aortic regurgitation due to acquired 
aorto-ventricular tunnel as a complication of infective endocarditis. 
3.3 Pathophysiology of acute AI 
In acute severe AR, the sudden large regurgitant volume is imposed on a left ventricle of 
normal size that has not had time to accommodate the volume overload. With an abrupt 
increase in end-diastolic volume, the ventricle operates on the steep portion of a normal 
diastolic pressure-volume relationship, and LV end-diastolic and left atrial pressures may 
increase rapidly and dramatically. The Frank-Starling mechanism is used, but the inability 
of the ventricle to develop compensatory chamber dilatation acutely results in a decrease in 
forward stroke volume. Although tachycardia develops as a compensatory mechanism to 
maintain cardiac output, this is often insufficient. Hence, patients frequently present with 
pulmonary edema or cardiogenic shock. Acute AR creates especially marked hemodynamic 
changes in patients with pre-existing pressure overload hypertrophy, in whom the small, 
noncompliant LV cavity is set on an even steeper diastolic pressurevolume relationship and 
has reduced preload reserve. Examples of this latter situation include aortic dissection in 
patients with systemic hypertension, infective endocarditis in patients with pre-existing AS, 
and acute regurgitation after balloon valvotomy or surgical commissurotomy for congenital 
AS (Bonow 2006 ACC AHA guidelines). 
3.4 Pathophysiology of chronic AI 
The left ventricle responds to the volume load of chronic AR with a series of compensatory 
mechanisms, including an increase in end-diastolic volume, an increase in chamber 
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compliance that accommodates the increased volume without an increase in filling 
pressures, and a combination of eccentric and concentric hypertrophy. The greater diastolic 
volume permits the ventricle to eject a large total stroke volume to maintain forward stroke 
volume in the normal range. This is accomplished through rearrangement of myocardial 
fibers with the addition of new sarcomeres and development of eccentric LV hypertrophy 
(Grossman 1975). As a result, preload at the sarcomere level remains normal or near normal, 
and the ventricle retains its preload reserve. The enhanced total stroke volume is achieved 
through normal performance of each contractile unit along the enlarged circumference (Ross 
1972). Thus, LV ejection performance is normal, and ejection phase indexes such as ejection 
fraction and fractional shortening remain in the normal range. However, the enlarged 
chamber size, with the associated increase in systolic wall stress, also results in an increase 
in LV afterload and is a stimulus for further hypertrophy (Grossman 1975). Thus, AR 
represents a condition of combined volume overload and pressure overload. As the disease 
progresses, recruitment of preload reserve and compensatory hypertrophy permit the 
ventricle to maintain normal ejection performance despite the elevated afterload (Ricci 
1982). The majority of patients remain asymptomatic throughout this compensated phase, 
which may last for decades. Vasodilator therapy has the potential to reduce the 
hemodynamic burden in such patients. For purposes of the subsequent discussion, patients 
with normal LV systolic function will be defined as those with normal LV ejection fraction at 
rest. It is recognized that other indices of LV function may not be “normal” in chronic severe 
AR and that the hemodynamic abnormalities noted above may be considerable. It is also 
recognized that the transition to LV systolic dysfunction represents a continuum and that 
there is no single hemodynamic measurement that represents the absolute boundary 
between normal LV systolic function and LV systolic dysfunction. In a large subset of 
patients, the balance between afterload excess, preload reserve, and hypertrophy cannot be 
maintained indefinitely. Preload reserve may be exhausted, and/ or the hypertrophic 
response may be inadequate, so that further increases in afterload result in a reduction in 
ejection fraction, first into the low normal range and then below normal. Impaired 
myocardial contractility may also contribute to this process. Patients often develop dyspnea 
at this point in the natural history. In addition, diminished coronary flow reserve in the 
hypertrophied myocardium may result in exertional angina. However, this transition may 
be much more insidious, and it is possible for patients to remain asymptomatic until severe 
LV dysfunction has developed. LV systolic dysfunction (defined as an ejection fraction 
below normal at rest) is initially a reversible phenomenon related predominantly to 
afterload excess, and full recovery of LV size and function is possible with AVR. With time, 
during which the ventricle develops progressive chamber enlargement and a more 
spherical geometry, depressed myocardial contractility predominates over excessive 
loading as the cause of progressive systolic dysfunction. This can progress to the extent that 
the full benefit of surgical correction of the regurgitant lesion, in terms of recovery of LV 
function and improved survival, can no longer be achieved AS (Bonow 2006 ACC AHA 
guidelines). 
3.5 Signs and symptoms 
Similar to AS, AI is also asymptomatic for a long time, and at the time of diagnosis many of 
them have dilated LVs with severe dysfunction. The first sign is almost always exercise 
intolerance, followed by chest pain sudden cardiac death, syncope and heart failure. Such as 
AS symptoms are most commonly seen during exercise, but exceptionally the chest pain can 
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be seen during sleep. The reason is the bradycardia during sleep. Bradycardia will increase 
the diastolic time during a cardiac cycle. The more the diastolic interval the more the 
regurgitant volume (because the regurgitation of the blood occurs in diastolic interval). The 
reason of angina is coronary artery disease in a fraction of patients but even in the absence 
of coronary artery disease angina can be seen. In these patients the reason of angina is 
decreased coronary flow reserve because of decreased driving pressure (low aortic diastolic 
pressure) and increased LV diastolic pressure (Nitenberg 1988). As in AS sudden cardiac 
death is more prevalent in symptomatic patients. In physical examination there are couples 
of sings that can help in diagnosis of AI and almost all of them are because of high stroke 
volume. Bounding pulse is the vigorous large pulses that can be palpated in sever AI and is 
because of high cardiac output and low diastolic pressure. Muller sign is the pulsation of 
uvula with each heart beat and is again because of high cardiac output. De Musset’s sign is 
the bobbing motion of the head with the heart beat. Becker’s sign is the pulsation of retinal 
vessels with beating heart. These peripheral signs are seen in chronic sever AI and are 
absent in acute AI, because they are the result of high stroke volume and cardiac output. 
In chronic AI the heart has the time to compensate and can pump the extra amount of 
blood that has been regurgitated to LV in diastole, but in acute severe AI the LV will fail 
suddenly and the stroke volume will remain the same or even decrease, so these sings 
would be absent. The cardiac auscultation of patients with AI will show a diastolic 
murmur that starts from early diastole in a decrescendo manner and regarding the severity 
of AI and its chronicity it will extend throughout the diastole. In acute severe AI the 
murmur will end soon in middle of diastole, but in chronic severe AI it will extend to the 
end of diastolic time.   
3.6 Evaluation of patients with AI 
The evaluation begins with seeking the history of any disease that can be associated with AI 
and also looking for subtle symptoms of AI such as nocturnal chest pain and heart failure. It 
is very important to be able to diagnose AI in physical examination because AI will remain 
silent for many years and finally it will be emerged as an irreversible LV dysfunction when 
the therapy will have little effect. There are great amount of signs in the physical 
examination of a patient with AI such as Muller sign, Becker sign. They can be used for 
diagnosis and determining the severity of the problem. ECG showed eccentric LV 
hypertrophy with atrioventricular and interventricular (specially in LV dysfunction) 
conduction abnormalities. These ECG findings are neither specific nor sensitive. CXR shows 
huge cardiomegally with aortic dilatation. In patients with AS the ascending aorta will be 
dilated but in AI the entire aorta is dilated. Also in AS the rate of aortic valve calcification is 
higher, which can be seen in CXR. Echocardiography is again the most frequent way of 
diagnosing and evaluating AI which is done via its divers modalities (Table 2).All of the 
patients with AI should undergo serial echocardiography with specific intervals in order to 
prevent the irreversible LV damage (Figure 5). As soon as the time the symptoms begin or 
the LV dilates or the LV dysfunction starts surgical treatment is indicated. CT scan and MRI 
are also used in this matter specially when evaluation of the aorta itself is also needed. They 
can precisely measure the size of the aortic root and ascending aorta. These sizes are 
extremely important when the surgery is planned, because the ascending aorta may be 
replaced as well. Cardiac catheterization is reserved for those cases which need further 
evaluation after previously mentioned modalities. 
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Table 3. Echocardiographic evaluation of AI severity (Source: American Heart Association, 
Inc.) 
 
Chronic Severe Aortic Regurgitation
Clinical evaluation + Echo
Class I
Class IIb
Class I
Class IIa
RVG or MRI
Class I
No
    No, or
initial study
    No, or
initial study
Reevaluation
Reevaluate
  and Echo
      3 mo
Reevaluate
  and Echo
      3 mo
Symptoms
Yes
Yes Yes Yes
Stable? Stable?Stable?
Clinical eval
 every 6 mo
 Echo every
     12 mo
Clinical eval
     every
   6-12 mo
Echo every
     12 mo
Clinical eval
 every 6 mo
 Echo every
      6 mo
Consider hemodynamic
    response to exercise
SD < 45 mm or
   DD< 60 mm
SD 45-50 mm or
   DD 60-70 mm
SD 50-55 mm or
   DD 70-75 mm
 SD >55 mm 
          or
DD >75 mm
LV dimensions?
Normal EF
Normal
Abnormal
EF borderline or uncertain EF of 50% or less
No symptoms
LV function?
Equivocal
AVR
Exercise test
Symptoms?
 
Fig. 5. Management of patients with severe AI (Source: American Heart Association, Inc.) 
www.intechopen.com
 Aortic Valve 
 
66 
3.7 Medical treatment of AI 
There is a great controversy in this field. Some believe that amlodipine can postpone the 
time of surgery or preserve the LV function during a 6 months period of time. Most 
specialists believe that there is no proper medical therapy for AI except in those with high 
operative mortality and those with advanced LV dysfunction as a part of heart failure 
management. In these patients specially vasodilators are indicated. Meticulous medical 
follow up is needed before and after AVR as in aortic stenosis. In those with advanced LV 
dysfunction and high risk for surgery medical treatment with the same medications as other 
heart failure patients is started. The exception are those drugs that decrease the heart rate 
because they can prolong the diastolic time and as the result the regurgitant volume.  
3.8 Endovascular therapy of AI 
 There has been a great advance in this field in recent years, and developing techniques of 
precutaneous AVR are developing which is done in selected patients. But more advances is 
this field is needed and its not performed routinely because of high failure rate. 
3.9 Surgical therapy of AI 
This is the mainstay of management of AI and the timing of operation is determined 
through specific guidelines (Figure 5). This timing is performed specially with determining 
the size of the LV as well as its function. The other important issue is the symptoms of the 
patient. Operation is indicated when the patient becomes symptomatic. Aortic valve repair 
is reserved for specific situation such as myxomatous valve disease, traumatic or infective 
cases. It is not performed it most of the patients because of its failure rate. AVR is the most 
common procedure used with or without root replacement (Bental procedure). Root 
replacement is indicated in those patients that have dilated or dissected root. Selection of the 
valve can be done via specific guidelines. After AVR the dilatation and dysfunction of the 
LV will be reversed if the operation is performed on the proper time. Short-term and long-
term improvement in left ventricular systolic function after operation is related significantly 
to the early reduction in left ventricular dilatation arising from correction of left ventricular 
volume overload. Moreover, late improvement in ejection fraction occurs commonly in 
patients with an early increase in ejection fraction after valve replacement but is unlikely to 
occur in patients with no change in ejection fraction during the first 6 months after operation 
(Bonow 2006 ACC AHA guidelines)(Bonow 1983)(Bonow 1988)(Bonow 1984). 
3.10 Natural course of AI 
As in AS the patients with AI have a good prognosis until they are asymptomatic (Tornos 
1995). Also the LV function and the size of the LV are important prognostic factors. 
Decreased LV contractility and dilated LV are predictors of poor prognosis, so small LV 
sizes and normal ejection fraction show good long term and post operative survivals. But in 
patients who become symptomatic the prognosis worsens rapidly and the expected survival 
is about 2 to 4 years in these patients if surgical intervention is not performed. But even in 
these patients if the AVR is performed in the proper time the survival and prognosis is 
excellent. Bonow et al.,(1988) reported that in asymptomatic patients with normal left 
ventricular function, death is rare, and less than 4% per year require aortic valve 
replacement because symptoms or left ventricular dysfunction develop. When aortic valve 
replacement is delayed until symptoms or left ventricular dysfunction develop, postoperative 
survival is excellent, and left ventricular size and function improve postoperatively. Hence, 
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"prophylactic" aortic valve replacement to preserve left ventricular function should not be 
performed in asymptomatic patients with severe aortic regurgitation and normal left 
ventricular function.  
4. Aortic valve prosthesis 
They can be mainly classified into two types: Metallic (Figure 6) and Bioprosthetic (Figure 7). 
 
 
Fig. 6. Metallic valve 
 
Fig. 7. Bioprosthetic valve 
Metallic valves are made of different compound such as titanium and have different types. 
They would not degenerate over time but their disadvantage is that blood can clot on their 
surface and cause their dysfunction or systemic embolization. Valve dysfunction can be fatal 
if severe , by causing cardiac dysfunction. These dysfunctions are managed either surgically 
or medically depending on their severity and the size of the clot. To prevent these 
complications AVR patients should receive oral anticoagulation for their life time in order to 
prevent clot formation on the valve. Precise monitoring is needed for the patients who use 
these medications because overdosing may cause abnormal and occasionally fatal bleedings. 
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Under dosing can culminate in clot formation and the aforementioned complications. The 
most prevalent drug is warfarin which prevents clot formation by inhibiting activation of 
clotting factors in the liver. The medical follow up of the patients receiving warfarin is by 
serial checking of International Normalization Ratio (INR) and Prothrombin Time (PT). The 
optimal INR is about 2.5 in most AVR patients (Butchart 1991)(Cannegieter 1994). 
Bioprosthetic valves on the other hand degenerate over time and even may need 
reoperation, but they do not need constant anticoagulation to prevent clot formation. So the 
risks associated with anticoagulation such as bleeding is less than metallic valves. 
The selection of specific valve is then determined in every patients considering these 
properties. In a young man who is going to have the valve for many years replacing the 
valve with a bioprosthetic will expose him to the risk of reoperation because of valve 
degeneration, so the metallic valve is preferred. On the other hand in an old lady who is 
high risk for bleeding the bioprosthetic is preferred.  
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